These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23054842)

  • 61. Meta-analysis of the effect of preoperative breast MRI on the surgical management of ductal carcinoma in situ.
    Fancellu A; Turner RM; Dixon JM; Pinna A; Cottu P; Houssami N
    Br J Surg; 2015 Jul; 102(8):883-93. PubMed ID: 25919321
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effect of margins on the clinical management of ductal carcinoma in situ of the breast.
    Meijnen P; Gilhuijs KG; Rutgers EJ
    J Surg Oncol; 2008 Dec; 98(8):579-84. PubMed ID: 19072848
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
    Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
    Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Preoperative CT evaluation of intraductal spread of breast cancer and surgical treatment.
    Akashi-Tanaka S
    Breast Cancer; 2013 Jan; 20(1):21-5. PubMed ID: 22161276
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Three-dimensional RODEO breast MR imaging of lesions containing ductal carcinoma in situ.
    Soderstrom CE; Harms SE; Copit DS; Evans WP; Savino DA; Krakos PA; Farrell RS; Flamig DP
    Radiology; 1996 Nov; 201(2):427-32. PubMed ID: 8888235
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.
    Solin LJ; Fourquet A; Vicini FA; Haffty B; Taylor M; McCormick B; McNeese M; Pierce LJ; Landmann C; Olivotto IA; Borger J; de La Rochefordiere A; Schultz DJ
    Cancer; 2001 Mar; 91(6):1090-7. PubMed ID: 11267953
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Extension of ductal carcinoma in situ: histopathological association with MR imaging and mammography.
    Shiraishi A; Kurosaki Y; Maehara T; Suzuki M; Kurosumi M
    Magn Reson Med Sci; 2003 Dec; 2(4):159-63. PubMed ID: 16222109
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of magnetic resonance imaging and multidetector computed tomography for evaluating intraductal tumor extension of breast cancer.
    Uematsu T
    Jpn J Radiol; 2010 Oct; 28(8):563-70. PubMed ID: 20972855
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
    Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
    Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Can dedicated breast PET help to reduce overdiagnosis and overtreatment by differentiating between indolent and potentially aggressive ductal carcinoma in situ?
    Graña-López L; Herranz M; Domínguez-Prado I; Argibay S; Villares Á; Vázquez-Caruncho M
    Eur Radiol; 2020 Jan; 30(1):514-522. PubMed ID: 31375867
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Reexcision for positive margins in the surgery of ductal carcinoma in situ: are there any risk factors?].
    Devouge P; Phalippou J; Martin de Beauce S; Kerdraon O; Prolongeau JF; Collinet P; Vinatier D; Boulanger L
    Gynecol Obstet Fertil; 2013 Apr; 41(4):228-34. PubMed ID: 23562544
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prospective study of wide excision alone for ductal carcinoma in situ of the breast.
    Wong JS; Kaelin CM; Troyan SL; Gadd MA; Gelman R; Lester SC; Schnitt SJ; Sgroi DC; Silver BJ; Harris JR; Smith BL
    J Clin Oncol; 2006 Mar; 24(7):1031-6. PubMed ID: 16461781
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The clinical significance of breast MRI in the management of ductal carcinoma in situ diagnosed on needle biopsy.
    Miyashita M; Amano G; Ishida T; Tamaki K; Uchimura F; Ono T; Yajima M; Kuriya Y; Ohuchi N
    Jpn J Clin Oncol; 2013 Jun; 43(6):654-63. PubMed ID: 23592884
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Assessing residual cancer cells using MRI and US after preoperative chemotherapy in primary breast cancer to omit surgery.
    Iwase M; Sawaki M; Hattori M; Yoshimura A; Ishiguro J; Kotani H; Gondo N; Adachi Y; Kataoka A; Onishi S; Sugino K; Iwata H
    Breast Cancer; 2018 Sep; 25(5):583-589. PubMed ID: 29619758
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Accelerated partial breast irradiation for pure ductal carcinoma in situ.
    Park SS; Grills IS; Chen PY; Kestin LL; Ghilezan MI; Wallace M; Martinez AM; Vicini FA
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):403-8. PubMed ID: 20800374
    [TBL] [Abstract][Full Text] [Related]  

  • 76. MRI accurately depicts underlying DCIS in a patient with Paget's disease of the breast without palpable mass and mammography findings.
    Amano G; Yajima M; Moroboshi Y; Kuriya Y; Ohuchi N
    Jpn J Clin Oncol; 2005 Mar; 35(3):149-53. PubMed ID: 15741305
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ultrasound Breast Elastographic Evaluation of Mass-Forming Ductal Carcinoma-in-situ with Histological Correlation - New Findings for a Toothpaste Sign.
    Leong LC; Sim LS; Jara-Lazaro AR; Tan PH
    Asian Pac J Cancer Prev; 2016; 17(5):2673-8. PubMed ID: 27268649
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast.
    Ringberg A; Idvall I; Fernö M; Anderson H; Anagnostaki L; Boiesen P; Bondesson L; Holm E; Johansson S; Lindholm K; Ljungberg O; Ostberg G
    Eur J Surg Oncol; 2000 Aug; 26(5):444-51. PubMed ID: 11016463
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Factors affecting successful breast conservation for ductal carcinoma in situ.
    Dillon MF; Mc Dermott EW; O'Doherty A; Quinn CM; Hill AD; O'Higgins N
    Ann Surg Oncol; 2007 May; 14(5):1618-28. PubMed ID: 17443388
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Magnetic resonance imaging of ductal carcinoma in situ: what is its clinical application? A review.
    Schouten van der Velden AP; Schlooz-Vries MS; Boetes C; Wobbes T
    Am J Surg; 2009 Aug; 198(2):262-9. PubMed ID: 19375068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.